Kevyn L Hart

METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.

J. Li, L. Ghoda, S. Fernandes, 2023, Blood cancer discovery.

Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns

Angela N. Brooks, M. V. van Baren, Catherine J. Wu, 2018, Nature Communications.

MGA deletion leads to Richter’s transformation via modulation of mitochondrial OXPHOS

Jibin Zhang, T. Siddiqi, Steven T. Rosen, 2023, bioRxiv.

Diverse Approaches to Gene Therapy of Sickle Cell Disease.

D. Kohn, Shanna L White, Kevyn L Hart, 2022, Annual review of medicine.

Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials

D. Kohn, Kevyn Hart, Eva E. Segura, 2023, Viruses.

SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation

Shondra M. Pruett-Miller, T. Bowman, Catherine J. Wu, 2023, The Journal of clinical investigation.

MGA deletion leads to Richter’s transformation by modulating mitochondrial OXPHOS

M. Buchner, Meiling Jin, Tingting Liu, 2024, Science Translational Medicine.

Expression of Sf3b1-K700E accelerates the Development of Chronic Lymphocytic Leukemia in a Del(13q) Murine Model

D. Neuberg, Catherine J. Wu, L. Rassenti, 2020 .